Use of Peripheral Blood Mononuclear Cells Mitochondrial DNA Content to Detect Hepatocellular Carcinoma in Hepatitis B Virus Infected Nigerians
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Use of Peripheral Blood Mononuclear Cells Mitochondrial DNA Content to Detect Hepatocellular Carcinoma in Hepatitis B Virus Infected Nigerians
Principal Institution
College of Medicine, University of Lagos
Principal Investigator(s) (PI)
Adisa, Rahmat Adetutu
Project Contact Information
Email:
radisa22@yahoo.com
Year(s) Awarded
2023-2028
Country
Nigeria
Project Description
The use of a minimally invasive quantitative molecular based mitochondrial DNA content of peripheral blood mononuclear cells (PBMC) as diagnostic biomarker to screen chronic hepatitis B (CHB) infected persons in Nigeria will promote early detection of hepatocellular carcinoma (HCC), and minimize hazards and costs. Dr. Adisa will leverage resources for the proposed research and training activities, as well as the support and guidance provided by my mentors and co-mentors in U.S., India, and Nigeria, to transition to an independent research and translate the research outcomes into beneficial public health policy and practice.
Related World Regions / Countries